Clinical Trials Browser

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Muscle Invasive Bladder Cancer (MIBC)

Carcinoma, Renal Cell

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Carcinoma, Transitional Cell

High-risk Renal Cell Carcinoma

Muscle-invasive Bladder Urothelial Carcinoma

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Neoplasms

Muscle Invasive Bladder Cancer (MIBC)

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Penile Neoplasms

Carcinoma, Transitional Cell

Urinary Bladder Neoplasms

Carcinoma, Renal Cell

Advanced Urothelial Carcinoma

Carcinoma, Transitional Cell

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

Carcinoma, Transitional Cell

Muscle Invasive Bladder Cancer

Upper Tract Urinary Carcinoma

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma

Carcinoma, Transitional Cell

Carcinoma, Transitional Cell

Kidney Neoplasms, Neoplasm Metastasis

Clinical Trials

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

PLUTO

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

TUORA

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

BCIRT-01

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment

OHAI-NMIBC-01

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

Combination of Toripalimab and JS004 Therapy for ccRCC

9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer

9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma